Advertisement
Advertisement

RLMD

RLMD logo

Relmada Therapeutics, Inc. Common Stock

6.54
USD
Sponsored
-0.12
-1.80%
Mar 26, 15:59 UTC -4
Closed
exchange

After-Market

6.53

-0.01
-0.23%

Relmada Therapeutics, Inc. Common Stock Financial Snapshot

Market Cap
684.41M
Beta
0.72
Earnings Per Share (EPS)
-1.45
Price-to-Book (P/B) Ratio
5.17
Operating Margin
--
Total Debt/Equity (D/E)
0.00%
P/E Ratio
--
Return on Equity (ROE)
-170.83%
Current Ratio
2.86%
Free Cash Flow
-31.19M

Earnings Chart

Advertisement